ADHD
Attention-deficit/hyperactivity disorder. No supporting evidence, and acute cannabis use impairs attention.
What the evidence says
No supporting evidence. NASEM found moderate evidence that acute cannabis use impairs learning, memory, and attention.
There is no NASEM conclusion supporting cannabis for ADHD, and the direction of the available evidence is unfavourable. NASEM found moderate evidence that acute cannabis use impairs learning, memory, and attention — the exact domains ADHD already affects.
CDC notes that cannabis use before age 18 may affect how the brain builds connections for attention, memory, and learning, and that those effects may be long-lasting or permanent. ADHD is frequently diagnosed and treated in that age range.
We do not recommend cannabis for ADHD.
We do not recommend cannabis for this
Rather than suggest a product profile, we are telling you the evidence points the other way. Talk to a clinician about options with better support.
Talk to a doctor if
- • You suspect ADHD — get a proper assessment
- • You are under 25
- • You are using cannabis to manage focus and it is not working
Related conditions
- Multiple sclerosis spasticityMuscle stiffness and spasm in multiple sclerosis. Substantial evidence for patient-reported improvement; weaker for clinician-measured.
- Tourette syndromeTic disorder. Limited evidence for THC capsules.
- DementiaNASEM found limited evidence that cannabinoids are INEFFECTIVE for dementia symptoms.
- Epilepsy and seizure disordersPrescription CBD has strong RCT evidence in three specific syndromes. Dispensary products do not.